107 related articles for article (PubMed ID: 38726808)
1. Monitoring advanced gastrointestinal stromal tumor with circulating tumor DNA.
Gómez-Peregrina D; Cicala CM; Serrano C
Curr Opin Oncol; 2024 Jul; 36(4):282-290. PubMed ID: 38726808
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Serrano C; Bauer S; Gómez-Peregrina D; Kang YK; Jones RL; Rutkowski P; Mir O; Heinrich MC; Tap WD; Newberry K; Grassian A; Shi H; Bialick S; Schöffski P; Pantaleo MA; von Mehren M; Trent JC; George S
Ann Oncol; 2023 Jul; 34(7):615-625. PubMed ID: 37105265
[TBL] [Abstract][Full Text] [Related]
3. Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
Serrano C; Vivancos A; López-Pousa A; Matito J; Mancuso FM; Valverde C; Quiroga S; Landolfi S; Castro S; Dopazo C; Sebio A; Virgili AC; Menso MM; Martín-Broto J; Sansó M; García-Valverde A; Rosell J; Fletcher JA; George S; Carles J; Arribas J
BMC Cancer; 2020 Feb; 20(1):99. PubMed ID: 32024476
[TBL] [Abstract][Full Text] [Related]
4. Circulating cKIT and PDGFRA DNA indicates disease activity in Gastrointestinal Stromal Tumor (GIST).
Jilg S; Rassner M; Maier J; Waldeck S; Kehl V; Follo M; Philipp U; Sauter A; Specht K; Mitschke J; Lange T; Bauer S; Jost PJ; Peschel C; Duyster J; Gaiser T; Hohenberger P; von Bubnoff N
Int J Cancer; 2019 Oct; 145(8):2292-2303. PubMed ID: 30882891
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and Treatment Monitoring of a Patient with Gastrointestinal Stromal Tumor by Next-Generation Sequencing and Droplet Digital Polymerase Chain Reaction Assay of a PDGFRA Mutation in Plasma-Derived Cell-Free Tumor DNA.
Boonstra PA; Ter Elst A; Tibbesma M; Gietema JA; Schuuring E; Reyners AKL
Oncologist; 2019 Jun; 24(6):e387-e390. PubMed ID: 30670599
[TBL] [Abstract][Full Text] [Related]
6. Development of Highly Sensitive Digital Droplet PCR for Detection of cKIT Mutations in Circulating Free DNA That Mediate Resistance to TKI Treatment for Gastrointestinal Stromal Tumor (GIST).
Rassner M; Waldeck S; Follo M; Jilg S; Philipp U; Jolic M; Wehrle J; Jost PJ; Peschel C; Illert AL; Duyster J; Scherer F; von Bubnoff N
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982486
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor.
Namløs HM; Boye K; Mishkin SJ; Barøy T; Lorenz S; Bjerkehagen B; Stratford EW; Munthe E; Kudlow BA; Myklebost O; Meza-Zepeda LA
Mol Cancer Ther; 2018 Nov; 17(11):2473-2480. PubMed ID: 30097488
[TBL] [Abstract][Full Text] [Related]
8. Pre-and Postoperative Circulating Tumour DNA in Patients With Gastrointestinal Stromal Tumour - A Methodological Assessment Study.
Brinch CM; Aggerholm-Pedersen N; Poulsen TS; Skovrider-Ruminski W; DE Heer P; Penninga L; Krarup-Hansen A; Hogdall E
Anticancer Res; 2022 Nov; 42(11):5527-5537. PubMed ID: 36288871
[TBL] [Abstract][Full Text] [Related]
9. Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GIST.
Xu H; Chen L; Shao Y; Zhu D; Zhi X; Zhang Q; Li F; Xu J; Liu X; Xu Z
Mol Cancer Ther; 2018 Jan; 17(1):290-296. PubMed ID: 29133619
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic agents in gastrointestinal stromal tumours.
Falkenhorst J; Hamacher R; Bauer S
Curr Opin Oncol; 2019 Jul; 31(4):322-328. PubMed ID: 31033566
[TBL] [Abstract][Full Text] [Related]
11. [The importance of mutational status in prognosis and therapy of GIST].
Comandone A; Boglione A
Recenti Prog Med; 2015 Jan; 106(1):17-22. PubMed ID: 25621775
[TBL] [Abstract][Full Text] [Related]
12. Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors.
Serrano C; Leal A; Kuang Y; Morgan JA; Barysauskas CM; Phallen J; Triplett O; Mariño-Enríquez A; Wagner AJ; Demetri GD; Velculescu VE; Paweletz CP; Fletcher JA; George S
Clin Cancer Res; 2019 Dec; 25(24):7287-7293. PubMed ID: 31471313
[TBL] [Abstract][Full Text] [Related]
13. Detecting Secondary C-KIT Mutations in the Peripheral Blood of Patients with Imatinib-Resistant Gastrointestinal Stromal Tumor.
Wada N; Kurokawa Y; Takahashi T; Hamakawa T; Hirota S; Naka T; Miyazaki Y; Makino T; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Oncology; 2016; 90(2):112-7. PubMed ID: 26779618
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy in Gastrointestinal Stromal Tumors: Ready for Prime Time?
Gómez-Peregrina D; García-Valverde A; Pilco-Janeta D; Serrano C
Curr Treat Options Oncol; 2021 Feb; 22(4):32. PubMed ID: 33641024
[TBL] [Abstract][Full Text] [Related]
15. Progress in determining response to treatment in gastrointestinal stromal tumor.
Arshad J; Ahmed J; Subhawong T; Trent JC
Expert Rev Anticancer Ther; 2020 Apr; 20(4):279-288. PubMed ID: 32191549
[No Abstract] [Full Text] [Related]
16. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors in the treatment of unresectable or metastatic gastrointestinal stromal tumors.
Nishida T; Doi T; Naito Y
Expert Opin Pharmacother; 2014 Oct; 15(14):1979-89. PubMed ID: 24990162
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033.
Heinrich MC; Rankin C; Blanke CD; Demetri GD; Borden EC; Ryan CW; von Mehren M; Blackstein ME; Priebat DA; Tap WD; Maki RG; Corless CL; Fletcher JA; Owzar K; Crowley JJ; Benjamin RS; Baker LH
JAMA Oncol; 2017 Jul; 3(7):944-952. PubMed ID: 28196207
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal stromal tumor: a review of current and emerging therapies.
Al-Share B; Alloghbi A; Al Hallak MN; Uddin H; Azmi A; Mohammad RM; Kim SH; Shields AF; Philip PA
Cancer Metastasis Rev; 2021 Jun; 40(2):625-641. PubMed ID: 33876372
[TBL] [Abstract][Full Text] [Related]
20. New treatments in advanced gastrointestinal stromal tumor.
Serrano C
Curr Opin Oncol; 2021 Jul; 33(4):323-328. PubMed ID: 33867479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]